Clinical Trials Browser

Myasthenia Gravis × Rituximab × 1 year × Clear all

NCT05868837 2025-08-01

REFINE

Phase 3 Recruiting

Myasthenia Gravis

NCT07071246 2025-07-17

Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis

Phase NA Active not recruiting

Myasthenia Gravis